SE447486B - Forfarande for kvantitativ bestemning av interferoner samt medel for genomforande av forfarandet - Google Patents
Forfarande for kvantitativ bestemning av interferoner samt medel for genomforande av forfarandetInfo
- Publication number
- SE447486B SE447486B SE8002595A SE8002595A SE447486B SE 447486 B SE447486 B SE 447486B SE 8002595 A SE8002595 A SE 8002595A SE 8002595 A SE8002595 A SE 8002595A SE 447486 B SE447486 B SE 447486B
- Authority
- SE
- Sweden
- Prior art keywords
- interferon
- cell culture
- cells
- enzyme
- amount
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 15
- 102000014150 Interferons Human genes 0.000 claims description 47
- 108010050904 Interferons Proteins 0.000 claims description 47
- 229940079322 interferon Drugs 0.000 claims description 46
- 210000004027 cell Anatomy 0.000 claims description 34
- 102000001253 Protein Kinase Human genes 0.000 claims description 16
- 108060006633 protein kinase Proteins 0.000 claims description 16
- 238000004113 cell culture Methods 0.000 claims description 11
- 108090000364 Ligases Proteins 0.000 claims description 8
- 102000003960 Ligases Human genes 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 6
- 210000000265 leukocyte Anatomy 0.000 claims description 6
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 claims description 5
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 claims description 5
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 210000004698 lymphocyte Anatomy 0.000 claims description 3
- 230000002285 radioactive effect Effects 0.000 claims description 3
- 208000036142 Viral infection Diseases 0.000 claims description 2
- 210000002950 fibroblast Anatomy 0.000 claims description 2
- 239000012139 lysis buffer Substances 0.000 claims description 2
- 239000002736 nonionic surfactant Substances 0.000 claims description 2
- 239000012086 standard solution Substances 0.000 claims description 2
- 230000009385 viral infection Effects 0.000 claims description 2
- 238000009585 enzyme analysis Methods 0.000 claims 1
- 239000011535 reaction buffer Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 description 30
- 108090000790 Enzymes Proteins 0.000 description 30
- 238000005259 measurement Methods 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical group CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000711975 Vesicular stomatitis virus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 210000000601 blood cell Anatomy 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- AEOBEOJCBAYXBA-UHFFFAOYSA-N A2P5P Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1OP(O)(O)=O AEOBEOJCBAYXBA-UHFFFAOYSA-N 0.000 description 2
- 206010000830 Acute leukaemia Diseases 0.000 description 2
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000003996 Interferon-beta Human genes 0.000 description 2
- 108090000467 Interferon-beta Proteins 0.000 description 2
- 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 206010025135 lupus erythematosus Diseases 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 150000004712 monophosphates Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 206010000871 Acute monocytic leukaemia Diseases 0.000 description 1
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 208000035489 Monocytic Acute Leukemia Diseases 0.000 description 1
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 108010049395 Prokaryotic Initiation Factor-2 Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000011481 absorbance measurement Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012997 ficoll-paque Substances 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 238000000021 kinase assay Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 108010062403 oligoisoadenylate synthetase E Proteins 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/555—Interferons [IFN]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/811—Interferon
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL57108A IL57108A (en) | 1979-04-22 | 1979-04-22 | Assay for the quantitative determination of interferon and a kit therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8002595L SE8002595L (sv) | 1980-10-23 |
| SE447486B true SE447486B (sv) | 1986-11-17 |
Family
ID=11050997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8002595A SE447486B (sv) | 1979-04-22 | 1980-04-03 | Forfarande for kvantitativ bestemning av interferoner samt medel for genomforande av forfarandet |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4302533A (enrdf_load_stackoverflow) |
| JP (1) | JPS55144898A (enrdf_load_stackoverflow) |
| DE (1) | DE3015462A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2455082A1 (enrdf_load_stackoverflow) |
| GB (1) | GB2048472B (enrdf_load_stackoverflow) |
| IL (1) | IL57108A (enrdf_load_stackoverflow) |
| IT (1) | IT1141293B (enrdf_load_stackoverflow) |
| SE (1) | SE447486B (enrdf_load_stackoverflow) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT72786B (en) | 1980-04-03 | 1983-01-10 | Biogen Nv | Process for producing dna sequences recombinant dna molecules and human fibroplast interferon-like polypeptides |
| FR2505845A1 (fr) * | 1981-05-13 | 1982-11-19 | Choay Sa | Procede de dosage de la 2',5'-oligo-adenylate-synthetase, methodes de detection d'une infection virale ou microbienne, de dosage de la concentration de l'interferon circulant ou present dans des tissus, apres administration de l'interferon, ou apres administration d'inducteurs de l'interferon et ensemble pret a l'emploi, ou kit, pour la mise en oeuvre desdits procedes de dosage et methodes de detection et de dosage |
| US4515890A (en) * | 1982-11-08 | 1985-05-07 | Abbott Laboratories | Immunoassay of terminal deoxynucleotidyl transferase |
| US4515781A (en) * | 1983-02-23 | 1985-05-07 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | 2',5'-Riboadenylate-morpholinoadenylate nucleotides |
| US4954617A (en) * | 1986-07-07 | 1990-09-04 | Trustees Of Dartmouth College | Monoclonal antibodies to FC receptors for immunoglobulin G on human mononuclear phagocytes |
| DE4206431A1 (de) * | 1992-02-29 | 1993-09-02 | Basf Lacke & Farben | Wasserverduennbare ueberzugsmittel |
| JP3467515B2 (ja) * | 1994-11-01 | 2003-11-17 | 財団法人ルイ・パストゥール医学研究センター | インターフェロン活性の測定法 |
| EP0864860A1 (en) * | 1997-03-10 | 1998-09-16 | Japan Science and Technology Corporation | Sample plate and multicapillary electrophoresis apparatus |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4061538A (en) * | 1973-04-04 | 1977-12-06 | Sandoz Ltd. | Enzymatically oxidizing interferon |
| US3910824A (en) * | 1973-10-18 | 1975-10-07 | Searle & Co | Interferon assay |
| US4241174A (en) * | 1978-11-24 | 1980-12-23 | Hoffmann-La Roche Inc. | Interferon assay |
-
1979
- 1979-04-22 IL IL57108A patent/IL57108A/xx unknown
-
1980
- 1980-04-03 SE SE8002595A patent/SE447486B/sv not_active IP Right Cessation
- 1980-04-11 US US06/139,697 patent/US4302533A/en not_active Expired - Lifetime
- 1980-04-16 GB GB8012524A patent/GB2048472B/en not_active Expired
- 1980-04-21 JP JP5280280A patent/JPS55144898A/ja active Granted
- 1980-04-21 IT IT21525/80A patent/IT1141293B/it active
- 1980-04-22 DE DE19803015462 patent/DE3015462A1/de active Granted
- 1980-04-22 FR FR8008992A patent/FR2455082A1/fr active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| GB2048472B (en) | 1983-10-26 |
| US4302533A (en) | 1981-11-24 |
| IL57108A (en) | 1981-12-31 |
| GB2048472A (en) | 1980-12-10 |
| SE8002595L (sv) | 1980-10-23 |
| IL57108A0 (en) | 1979-07-25 |
| FR2455082A1 (fr) | 1980-11-21 |
| DE3015462A1 (de) | 1980-10-30 |
| IT1141293B (it) | 1986-10-01 |
| JPH0152000B2 (enrdf_load_stackoverflow) | 1989-11-07 |
| DE3015462C2 (enrdf_load_stackoverflow) | 1992-07-02 |
| FR2455082B1 (enrdf_load_stackoverflow) | 1984-11-09 |
| JPS55144898A (en) | 1980-11-12 |
| IT8021525A0 (it) | 1980-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI60720B (fi) | Foerfarande och medel foer bestaemning av aktiviteten av kreatinkinas-mb | |
| Tung et al. | Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. | |
| Furman et al. | Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities | |
| da Fonseca-Wollheim | Preanalytical increase of ammonia in blood specimens from healthy subjects | |
| Ebadi et al. | MICROASSAY OF ADENOSINE‐3′, 5′‐MONOPHOSPHATE (CYCLIC AMP) IN BRAIN AND OTHER TISSUES BY THE LUCIFERIN‐LUCIFERASE SYSTEM 1 | |
| Issinger et al. | Phosphorylation in vitro of eukaryotic initiation factors IF-E2 and IF-E3 by protein kinases. | |
| Sonnabend et al. | Viral specific RNAs in infected cells | |
| SE447486B (sv) | Forfarande for kvantitativ bestemning av interferoner samt medel for genomforande av forfarandet | |
| Nelson et al. | Autoradiographic detection of DNA polymerase containing nuclei in sarcoma 180 ascites cells | |
| Hruby et al. | Encephalomyocarditis virus RNA: variations in polyadenylic acid content and biological activity | |
| Obara et al. | Ribosomal RNA in avian leukosis virus particles | |
| Bachmann et al. | Comparative cytochemical measurements in the diploid-tetraploid species pair of hylid frogs Hyla chrysoscelis and H. versicolor | |
| Graham | The chemical analysis of purified influenza virus A (PR8 strain) containing radioactive phosphorus | |
| US4046634A (en) | Assay of isoenzymes by ion exchange chromatography | |
| Fiala et al. | Deoxynucleotidase activity in rat liver and certain tumors | |
| Gillette et al. | Thymidine kinase activity in cardiac muscle during embryonic and postnatal development | |
| Field et al. | Isolation and characterization of acyclovir-resistant strains of herpes simplex virus | |
| Wedner et al. | Tyrosine phosphorylation of a 66,000 Mr soluble protein in lectin-activated human peripheral blood T lymphocytes. | |
| Freise et al. | Studies on the multiple forms of γ-glutamyltransferase | |
| Piffkó et al. | Biochemical properties of human tonsillar lymphocytes | |
| Kiessling et al. | Detection of reverse transcriptase activity in human cells | |
| Reese | In vitro initiation in the newt iris of some early molecular events of lens regeneration | |
| Allaudeen et al. | Cellular and Epstein-Barr virus specific DNA polymerases in virus-producing Burkitt's lymphoma cell lines | |
| Morris et al. | Effect of interleukin‐2 on cell proliferation, sister‐chromatid exchange induction, and nuclear stress protein phosphorylation in Pha‐stimulated fischer 344 rat spleen lymphocytes: Modulation by 2‐mercaptoethanol | |
| EP0094923B1 (en) | A method of determining dtk isoenzyme activity and the use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8002595-0 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8002595-0 Format of ref document f/p: F |